Lloyd James Payne

Part of Evotec SE, Cyprotex Discovery Ltd. is a British company that specializes in in vitro toxicology studies using a range of techniques such as cell-based assays, mass spectrometer, fluorescence imaging, and qrt-pcr endpoints. The company is based in Abingdon, UK. The company also offers mitochondrial toxicity assays including seahorse assay, glu/gal assay, mitochondrial biogenesis, mitochondrial membrane potential, and mitochondrial mass.

Cyprotex Ltd. provides pharmaceutical research and development services. It offers ADME and pharmacokinetic, Biosciences, in vitro skin and ocular testing, physicochemical profiling, in vitro toxicology, in silico prediction, and endocrine disruption. The company was founded by David Leahy in 1999 and is headquartered in Abingdon, the United Kingdom.